Ignite Creation Date:
2025-12-24 @ 7:36 PM
Ignite Modification Date:
2025-12-25 @ 5:17 PM
Study NCT ID:
NCT02577003
Status:
COMPLETED
Last Update Posted:
2018-09-04
First Post:
2015-10-14
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Double-blind Ipragliflozin Add-on Study in Japanese Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Sitagliptin (MK-0431J-843)
Sponsor:
Merck Sharp & Dohme LLC